• Despite the enormous amount of work involved in the treatment of BCC, there has been very little good-quality research on the efficacy of the treatment modalities used.
• Surgery and radiotherapy appear to be the most effective treatments. Other treatments might have some use, but none has been compared with surgery.
• The majority studies have been performed on low-risk BCCs, the results of which are probably not applicable to tumours of the morphoeic type shown in Figure 26.3. Specific trials or subgroup analyses are required for morphoeic tumours.
• Cryotherapy, although convenient and less expensive than surgery or radiotherapy, does not have better cure rates than surgery or radiotherapy (especially for lesions >2 cm). Cosmetic effect is better for surgery and comparable for radiotherapy.
• If cryosurgery is to be used, two freeze-thaw cycles are recommended for nodular and superficial facial lesions (Figures 26.1 and 26.2) if cure rates approaching equivalence to that of formal excision or radiotherapy are to be achieved.
• An RCT of PDT versus surgery is needed.
• Further studies for all of the interferon treatments and PDT that demonstrate greater efficacy are needed before they can be recommended.
• Broadband halogen light source may give cure rates and cosmetic outcome similar to laser light PDT with possible benefits of reduced costs, increased safety and ease of use.
• The efficacy of interferon alfa has not been directly compared with standard surgical treatment; inteferons are associated with significant side-effects, which may overshadow their usefulness, especially in the elderly. Interferon therapy requires several clinic visits.
• Increased short-term eradication of BCC using 5-FU in a phosphatidyl choline based vehicle to increase penetration should be compared with surgery, with long-term follow up.
• Preliminary studies suggest a high success rate (87-88%) for imiquimod in the treatment of superficial BCC using a once-daily regimen for 6 weeks and a useful (76%) treatment response when treating nodular BCC for 12 weeks. These results need to be confirmed in a long-term study (3-5 years) with excision surgery as a comparator.
• Studies comparing excision with predetermined margins versus Mohs' micrographic surgery in high-risk tumours would be useful.
Was this article helpful?
Do You Suffer From the Itching and Scaling of Psoriasis? Or the Chronic Agony of Psoriatic Arthritis? If so you are not ALONE! A whopping three percent of the world’s populations suffer from either condition! An incredible 56 million working hours are lost every year by psoriasis sufferers according to the National Psoriasis Foundation.